June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s imaging ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
May 25, 2017 — A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast ...
May 24, 2017 — A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
May 3, 2017 — Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based ...
Improving Efficiency and Reducing Waste The volume of computed tomography (CT) imaging exams continues to grow in the ...
March 13, 2017 — The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
March 10, 2017 — The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For ...
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report ...
February 2, 2017 — Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a label ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
January 30, 2017 — Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not ...
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of ...
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased a ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
December 5, 2016 — Bracco Diagnostics Inc. announced that CT Exprès — the first and only multi-dose, multi-patient ...
October 4, 2016 — GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change ...
September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...
September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum ultrasound system will be ...
July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement addressing ...
July 5, 2016 — A study appearing in the July 5 issue of JAMA assessed the association between gadolinium exposure and ...
June 1, 2016 — Alzeca Biosciences announced successful preliminary results for ADx, its novel, proprietary diagnostic ...
May 3, 2016 — The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 ...
June 16, 2017 